Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Aspira Women's Health Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q3 2023
- Shares held
- 715.3K
- +57.5K (+8.7%) vs. Q3 2023
- Total value
- $2.92M
- −$608.5K (−17.3%) vs. Q3 2023
- New holders
- 5
- 10 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 26 | $106 | 0.00% | +26 | New |
| Wells Fargo & Company | 49 | $200 | 0.00% | −106−68.4% | Reduced |
| Group One Trading, L.P. | 119 | $486 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 381 | $1.55K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 493 | $2.01K | 0.00% | +493 | New |
| Operose Advisors LLC | 1,000 | $4.08K | 0.00% | 00.0% | Unchanged |
| Castleview Partners, LLC | 1,316 | $5.37K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,864 | $7.61K | 0.00% | +1,444+343.8% | Added |
| JPMorgan Chase & Co | 2,074 | $8.46K | 0.00% | +4+0.2% | Added |
| Advisor Group Holdings, Inc. | 2,239 | $9.13K | 0.00% | −2,655−54.3% | Reduced |
| Morgan Stanley | 2,274 | $9.28K | 0.00% | +167+7.9% | Added |
| Royal Bank of Canada | 9,317 | $38.0K | 0.00% | +9,317 | New |
| HRT Financial LP | 11,262 | $45.0K | 0.00% | +11,262 | New |
| M&T Bank Corp | 14,999 | $61.2K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 15,365 | $62.7K | 0.00% | +15,365 | New |
| State Street Corp | 18,249 | $74.5K | 0.00% | +2,200+13.7% | Added |
| Northeast Financial Consultants Inc | 23,436 | $95.6K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 29,183 | $119.1K | 0.00% | +11,308+63.3% | Added |
| Northern Trust Corp | 36,049 | $147.1K | 0.00% | +25,047+227.7% | Added |
| Quantum Private Wealth, LLC | 50,156 | $204.6K | 0.09% | +21,788+76.8% | Added |
| Geode Capital Management, LLC | 57,329 | $234.0K | 0.00% | +5,571+10.8% | Added |
| BlackRock Inc. | 62,766 | $256.1K | 0.00% | −403−0.6% | Reduced |
| National Asset Management, Inc. | 179,371 | $731.8K | 0.02% | +53,997+43.1% | Added |
| Vanguard Group Inc | 196,007 | $799.7K | 0.00% | +13,162+7.2% | Added |
| Perkins Capital Management Inc | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −36,809−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,156−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,504−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |